Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Airbnb
TI
TickerTickle
Community Contributor
Airbnb (ABNB): Still one of the most interesting bets in travel
Key insights Airbnb is changing from a travel-only app to a full lifestyle platform (stays, rentals, experiences) International markets are growing faster than the US, which is slowing down Product experience is improving a lot, with AI making search and booking easier Regulations are becoming a big risk, especially in Europe where listings are getting removed The way people move around the world has changed. It’s not only about holidays anymore.
View narrative
US$163.75
FV
23.6% undervalued
intrinsic discount
12.00%
Revenue growth p.a.
Set Fair Value
11
users have liked this narrative
2
users have commented on this narrative
41
users have followed this narrative
New
narrative
ING Groep
PI
PittTheYounger
Community Contributor
ING leads the pack when it comes to pivoting towards non-lending income
ING, of course, is a bank; and banks don't like falling interest rates, right? For the dominant stream of income is their core business model, i.e. borrowing short-term and lending long-term, reaping the difference in interest rates in the process.
View narrative
€27.92
FV
23.7% undervalued
intrinsic discount
9.00%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
0
users have commented on this narrative
14
users have followed this narrative
New
narrative
Coles Group
RO
Robbo
Community Contributor
Coles (ASX: COL): Safe, Steady, and Surprisingly Cheap
The supermarket chain Coles is the kind of “boring” business that may have been overlooked as an investment opportunity. Although it was divested from Wesfarmers in 2018, Coles’ heritage traces back to 1914 — giving it over 110 years of history.
View narrative
AU$22.00
FV
4.3% undervalued
intrinsic discount
8.72%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
2
users have commented on this narrative
16
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Adaptive Biotechnologies
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
EMR Integration And Partnerships Will Reshape Clinical Diagnostics
Key Takeaways Expansion of clonoSEQ integration and higher reimbursement rates position the company for strong recurring revenue growth and improved gross margins. Advances in clinical and AI-driven immune medicine pipelines create future opportunities in pharma partnerships and innovative diagnostics, supporting long-term earnings potential.
View narrative
US$14.00
FV
6.9% undervalued
intrinsic discount
20.18%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
1 day ago
author updated this narrative
NovoCure
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
Regulatory Approvals And Global Launches Will Expand Oncology Reach
Key Takeaways Expanding clinical validation, real-world adoption, and reimbursement advances are driving broader access, higher utilization, and long-term revenue stability for NovoCure. Ongoing launches, new indications, and development of combination therapies position the company for sustained international growth and competitive strength in the oncology market.
View narrative
US$27.19
FV
56.9% undervalued
intrinsic discount
11.07%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
8
users have followed this narrative
1 day ago
author updated this narrative
Service Properties Trust
AN
AnalystLowTarget
Consensus Narrative from 2 Analysts
Remote Work, Alternative Lodging And High Debt Will Undermine Profitability
Key Takeaways Shifts in work trends and alternative lodging are weakening hotel demand, eroding pricing power, and exposing persistent revenue challenges. High tenant concentration and debt burdens heighten earnings volatility and limit financial flexibility amid rising costs and refinancing hurdles.
View narrative
US$2.00
FV
25.0% overvalued
intrinsic discount
-7.99%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Quanterix
AN
AnalystLowTarget
Consensus Narrative from 3 Analysts
Life Sciences Challenges Will Limit Prospects But Synergies Will Aid
Key Takeaways Growth opportunities from expanded technology and strategic partnerships are balanced by ongoing risks from high R&D spending, regulatory pressures, and integration challenges. Intensifying competition, healthcare budget constraints, and potential for technology commoditization threaten sustained revenue and margin improvement despite strong market fundamentals.
View narrative
US$6.00
FV
23.8% undervalued
intrinsic discount
12.24%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Agora
AN
AnalystLowTarget
Consensus Narrative from 2 Analysts
Regulatory Risks Will Stall AI Market Progress Yet Hope Lingers
Key Takeaways Expansion in AI-powered engagement and developer ecosystem boosts long-term potential, but uncertain adoption and rapid commoditization threaten sustained revenue and margin growth. Geographic concentration and evolving regulatory risks, especially in China, increase compliance costs and create obstacles to stable international market expansion.
View narrative
US$5.00
FV
26.6% undervalued
intrinsic discount
9.79%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Restaurant Brands Asia
AN
AnalystLowTarget
Consensus Narrative from 11 Analysts
Rising Regulatory Challenges And Market Saturation Will Erode Margins
Key Takeaways Rising health consciousness and regulatory scrutiny are likely to weigh on revenue growth and compress margins despite ongoing menu and digital innovation efforts. Urban challenges, competitive pressures, and brand concentration threaten expansion plans and expose revenues to volatility and operational uncertainty.
View narrative
₹76.00
FV
3.7% overvalued
intrinsic discount
14.60%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Hudson Pacific Properties
AN
AnalystLowTarget
Consensus Narrative from 11 Analysts
Oversupply And Tech Risks Will Drag Down West Coast Offices
Key Takeaways Reliance on tech-focused West Coast markets and ongoing demographic shifts expose the company to heightened vacancy and leasing risks. Elevated vacancy rates, market oversupply, and regulatory compliance costs continue to compress margins and delay earnings recovery.
View narrative
US$2.00
FV
34.5% overvalued
intrinsic discount
4.29%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Arteris
AN
AnalystLowTarget
Consensus Narrative from 4 Analysts
Trade Tensions And Risks Will Limit Markets Yet Yield Hope
Key Takeaways Revenue growth and market share are threatened by geopolitical shifts, industry consolidation, and increased international competition as countries localize semiconductor IP development. High dependency on key clients, rising R&D expenses, and pressures from open-source standards could limit pricing power, margin expansion, and long-term earnings stability.
View narrative
US$11.00
FV
14.6% undervalued
intrinsic discount
18.83%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
GrafTech International
AN
AnalystLowTarget
Consensus Narrative from 4 Analysts
Stricter Emission Standards Will Erode Profitability And Market Share
Key Takeaways Structural shifts toward greener steelmaking and alternative technologies threaten the core demand for graphite electrodes, undermining GrafTech's long-term growth prospects. Heightened regulations, customer concentration, and increased global competition pose risks to profitability, cost management, and revenue stability.
View narrative
US$0.80
FV
60.0% overvalued
intrinsic discount
28.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Value any company in seconds
Popular companies